ICU Medical, Inc.
ICUI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,784,286 | $2,402,836 | $3,758,733 | $5,033,032 |
| - Cash | $308,566 | $254,222 | $208,784 | $552,827 |
| + Debt | $1,641,662 | $1,704,717 | $1,734,303 | $45,690 |
| Enterprise Value | $5,117,382 | $3,853,331 | $5,284,252 | $4,525,895 |
| Revenue | $2,382,046 | $2,259,126 | $2,279,997 | $1,316,308 |
| % Growth | 5.4% | -0.9% | 73.2% | – |
| Gross Profit | $824,782 | $739,873 | $697,761 | $491,490 |
| % Margin | 34.6% | 32.8% | 30.6% | 37.3% |
| EBITDA | $42,964 | $253,202 | $191,547 | $223,458 |
| % Margin | 1.8% | 11.2% | 8.4% | 17% |
| Net Income | -$117,688 | -$29,655 | -$74,286 | $103,135 |
| % Margin | -4.9% | -1.3% | -3.3% | 7.8% |
| EPS Diluted | -4.83 | -1.23 | -3.11 | 4.74 |
| % Growth | -292.7% | 60.5% | -165.6% | – |
| Operating Cash Flow | $204,033 | $166,201 | -$62,129 | $267,538 |
| Capital Expenditures | -$79,373 | -$93,670 | -$99,329 | -$81,169 |
| Free Cash Flow | $124,660 | $72,531 | -$161,458 | $186,369 |